These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8687262)

  • 1. Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial.
    Nichol KL; Margolis KL; Lind A; Murdoch M; McFadden R; Hauge M; Magnan S; Drake M
    Arch Intern Med; 1996 Jul; 156(14):1546-50. PubMed ID: 8687262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effects associated with influenza vaccination in patients with COPD: a randomized controlled study.
    Wongsurakiat P; Maranetra KN; Gulprasutdilog P; Aksornint M; Srilum W; Ruengjam C; Sated W
    Respirology; 2004 Nov; 9(4):550-6. PubMed ID: 15612969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.
    Engler RJ; Nelson MR; Klote MM; VanRaden MJ; Huang CY; Cox NJ; Klimov A; Keitel WA; Nichol KL; Carr WW; Treanor JJ;
    Arch Intern Med; 2008 Dec; 168(22):2405-14. PubMed ID: 19064822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of vaccination against influenza in healthy, working adults.
    Nichol KL; Lind A; Margolis KL; Murdoch M; McFadden R; Hauge M; Magnan S; Drake M
    N Engl J Med; 1995 Oct; 333(14):889-93. PubMed ID: 7666874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccination in adults with asthma: safety of an inactivated trivalent influenza vaccine.
    Kmiecik T; Arnoux S; Kobryn A; Gorski P
    J Asthma; 2007 Dec; 44(10):817-22. PubMed ID: 18097856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acetaminophen on adverse effects of influenza vaccination in health care workers.
    Aoki FY; Yassi A; Cheang M; Murdzak C; Hammond GW; Seklà LH; Wright B
    CMAJ; 1993 Nov; 149(10):1425-30. PubMed ID: 8221426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence risk of oculorespiratory syndrome after influenza vaccination: randomized controlled trial of previously affected persons.
    De Serres G; Skowronski DM; Guay M; Rochette L; Jacobsen K; Fuller T; Duval B
    Arch Intern Med; 2004 Nov; 164(20):2266-72. PubMed ID: 15534165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: evidence from a controlled trial involving adults.
    Scheifele DW; Duval B; Russell ML; Warrington R; DeSerres G; Skowronski DM; Dionne M; Kellner J; Davies D; MacDonald J
    Clin Infect Dis; 2003 Apr; 36(7):850-7. PubMed ID: 12652385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
    Künzi V; Klap JM; Seiberling MK; Herzog C; Hartmann K; Kürsteiner O; Kompier R; Grimaldi R; Goudsmit J
    Vaccine; 2009 Jun; 27(27):3561-7. PubMed ID: 19464535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, double-blind, placebo-controlled trial to assess the rate of recurrence of oculorespiratory syndrome following influenza vaccination among persons previously affected.
    Skowronski DM; De Serres G; Scheifele D; Russell ML; Warrington R; Davies HD; Dionne M; Duval B; Kellner J; MacDonald J
    Clin Infect Dis; 2003 Oct; 37(8):1059-66. PubMed ID: 14523770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy.
    Hanania NA; Sockrider M; Castro M; Holbrook JT; Tonascia J; Wise R; Atmar RL;
    J Allergy Clin Immunol; 2004 Apr; 113(4):717-24. PubMed ID: 15100679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study.
    Bachert C; Chuchalin AG; Eisebitt R; Netayzhenko VZ; Voelker M
    Clin Ther; 2005 Jul; 27(7):993-1003. PubMed ID: 16154478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
    Holland D; Booy R; De Looze F; Eizenberg P; McDonald J; Karrasch J; McKeirnan M; Salem H; Mills G; Reid J; Weber F; Saville M
    J Infect Dis; 2008 Sep; 198(5):650-8. PubMed ID: 18652550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.
    Vesikari T; Karvonen A; Smith HM; Dunning A; Razmpour A; Saville MK; Gruber WC; Forrest BD
    Pediatrics; 2008 Mar; 121(3):e568-73. PubMed ID: 18299305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older.
    Kerzner B; Murray AV; Cheng E; Ifle R; Harvey PR; Tomlinson M; Barben JL; Rarrick K; Stek JE; Chung MO; Schödel FP; Wang WW; Xu J; Chan IS; Silber JL; Schlienger K
    J Am Geriatr Soc; 2007 Oct; 55(10):1499-507. PubMed ID: 17908055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial.
    Beran J; Vesikari T; Wertzova V; Karvonen A; Honegr K; Lindblad N; Van Belle P; Peeters M; Innis BL; Devaster JM
    J Infect Dis; 2009 Dec; 200(12):1861-9. PubMed ID: 19909082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents.
    Bergen R; Black S; Shinefield H; Lewis E; Ray P; Hansen J; Walker R; Hessel C; Cordova J; Mendelman PM
    Pediatr Infect Dis J; 2004 Feb; 23(2):138-44. PubMed ID: 14872180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactions after pneumococcal vaccine alone or in combination with influenza vaccine.
    Socan M; Frelih T; Janet E; Petras T; Peternelj B
    Vaccine; 2004 Aug; 22(23-24):3087-91. PubMed ID: 15297059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.